| Literature DB >> 10024051 |
Y M Chen1, R H Lin, C M Lee, C Y Fu, S C Chen, W J Syu.
Abstract
To study the association between anti-Gag and anti-Nef antibody reactivities and their correlations with disease progression, 174 HIV-1/AIDS patients were followed up for 1 year after they received triple therapy. The antibody reactivities were analyzed using a Western blot test with recombinant Gag and Nef proteins. The results showed that decreasing levels of anti-Gag or anti-Nef antibody correlate with disease progression defined by HIV-1 viral loads or T4 cell counts. After receiving triple treatment for 1 year, 8 of 38 (21.1%) Nef antibody-negative patients became positive, while only 9 of 125 (7.2%) Nef antibody-positive persons lost the antibody reactivity (p < 0.01). Therefore, HIV-1 Nef may serve as a clinical marker of disease progression.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10024051 DOI: 10.1089/088922299311691
Source DB: PubMed Journal: AIDS Res Hum Retroviruses ISSN: 0889-2229 Impact factor: 2.205